Cardiac Rhythm Management Market By Device Type | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Cardiac Rhythm Management Market
Cardiac Rhythm Management Market: By Device Type (Defibrillators, Pacemakers & Implantable Loop Recorder), By End-User (Hospitals, Home/Ambulatory & Others) & By Geography-Forecast (2016-2021)
Report Code : HCR 0199
Published: 03 March, 2016   No. of pages: 152

  • Report Description
  • Table of Contents
  • Customization Options
Cardiac rhythm management is a speciality function of cardiology which is involved in looking at heart rhythm disorders. It is a branch of cardiology which studies and monitors the heart rhythm to find out any disorders and suggest treatment of cardiac electrophysiology (the electrical conduction and disturbances of the heart). With technological advancement cardiac rhythm management function is performed through devices. These devices are used to provide therapeutic solutions to patients suffering from cardiac disorders such as cardiac arrhythmias, heart failure, and cardiac arrests leading to irregular heartbeat. Increasing population with cardiac diseases and growing penetration of such devices with advanced technology in healthcare system are some of the major driving factors cardiac rhythm market.

This report identifies the cardiac rhythm management market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cardiac rhythm management market.
Cardiac Rhythm Management Market

Globally North America dominated the market for cardiac rhythm management in 2015 due to improved and advanced healthcare infrastructure, rise in incidences of cardiac disorders, growing number people with of cardiovascular diseases, and higher healthcare expenditure in the region. North America is expected to continue its domination during the period of study and was followed by Europe and Asia-Pacific as the second and third largest markets respectively in 2015. However Asia-Pacific is expected to be the fastest growing market due to rapidly changing healthcare infrastructure, increasing medical tourism, increased healthcare expenditure in many developing economies.

This report on global cardiac rhythm management also covers different type of devices available for cardiac rhythm management, end-users of devices and market size in various geographical regions.

On the basis of cardiac rhythm management device types, this report is classified as follows covering all the major types of devices for cardiac rhythm management: Defibrillators (Implantable Cardioverter Defibrillator (ICD), Non Implantable Cardioverter Defibrillator (NICD) and Cardiac Resynchronization Therapy Defibrillator (CRT-D)), Pacemakers (Single Chamber Pacemakers, Dual Chamber Pacemakers and Cardiac Resynchronization Therapy Pacemaker (CRT-P)) and Implantable Loop Recorder

On the basis of end-use segments, this report on cardiac rhythm management is segmented as follows covering all major end-use segments of such devices: Hospitals,  Home/Ambulatory and Others

This is report has been further segmented into major regions, which includes detailed analysis of each region such as North America, Europe, Asia-Pacific (APAC) and Rest of the World (RoW) covering all the major country level markets for cardiac rhythm management in each of the region.

This report identifies all the major companies operating in the global cardiac rhythm management market. Some of the major companies’ profiles in detail are as follows:
  • Boston Scientific Corporation
  • Abbott Laboratories
  • St. Jude Medical Inc      
  • Philips Healthcare     
  • GE Healthcare
1. Cardiac Rhythm Management – Market Overview
2. Executive Summary 
3. Cardiac Rhythm Management Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Cardiac Rhythm Management – Market Forces
   4.1. Drivers
      4.1.1. Increasing awareness about inherited diseases
      4.1.2. Safe and low risk obstetric procedures for prenatal testing
   4.2. Restraints
      4.2.1. High Cost
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Cardiac Rhythm Management Market – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. Global Cardiac Rhythm Management Market By Device Type
   6.1. Defibrillators 
      6.1.1. Implantable Cardioverter Defibrillator (ICD)
      6.1.2. Non Implantable Cardioverter Defibrillator (NICD)
      6.1.3. Cardiac Resynchronization Therapy Defibrillator (CRT-D)
   6.2. Pacemakers
      6.2.1. Single Chamber Pacemakers
      6.2.2. Dual Chamber Pacemakers
      6.2.3. Cardiac Resynchronization Therapy Pacemaker (CRT-P)
   6.3. Implantable Loop Recorder
7. Global Cardiac Rhythm Management Market By End-Use
   7.1. Hospitals
   7.2. Home/Ambulatory
   7.3. Others
8. Global Cardiac Rhythm Management Market By Geography
   8.1. Europe
      8.1.1. Germany
      8.1.2. France
      8.1.3. Italy
      8.1.4. Spain
      8.1.5. Russia
      8.1.6. U.K.
      8.1.7. Rest of Europe
   8.2. Asia Pacific
      8.2.1. China
      8.2.2. India
      8.2.3. Japan
      8.2.4. South Korea
      8.2.5. Rest of Asia-Pacific
   8.3. North America 
      8.3.1. U.S.
      8.3.2. Canada
      8.3.3. Mexico
   8.4. Rest of the World (RoW)
      8.4.1. Brazil
      8.4.2. Rest of RoW
9. Cardiac Rhythm Management – Market Entropy
   9.1. Expansion
   9.2. Technological Developments
   9.3. Merger & Acquisitions and Joint Ventures
   9.4. Supply- Contract
10. Company Profiles
   10.1. Boston Scientific Corporation
      10.1.1.  Introduction
      10.1.2. Financials
      10.1.3. Key Insights
      10.1.4. Key Strategy
      10.1.5. Product Portfolio
      10.1.6. SWOT Analysis
   10.2. Abbott Laboratories
      10.2.1. Introduction
      10.2.2. Financials
      10.2.3. Key Insights
      10.2.4. Key Strategy
      10.2.5. Product Portfolio
      10.2.6. SWOT Analysis
   10.3. St. Jude Medical Inc      
      10.3.1. Introduction
      10.3.2. Financials
      10.3.3. Key Insights
      10.3.4. Key Strategy
      10.3.5. Product Portfolio
      10.3.6. SWOT Analysis
   10.4. Philips Healthcare     
      10.4.1. Introduction
      10.4.2. Financials
      10.4.3. Key Insights
      10.4.4. Key Strategy
      10.4.5. Product Portfolio
      10.4.6. SWOT Analysis
   10.5. GE Healthcare   
      10.5.1. Introduction
      10.5.2. Financials
      10.5.3. Key Insights
      10.5.4. Key Strategy
      10.5.5. Product Portfolio
      10.5.6. SWOT Analysis
   10.6. 3M pharmaceuticals     
      10.6.1. Introduction
      10.6.2. Financials
      10.6.3. Key Insights
      10.6.4. Key Strategy
      10.6.5. Product Portfolio
      10.6.6. SWOT Analysis
   10.7. Medtronic Plc  
      10.7.1. Introduction
      10.7.2. Financials
      10.7.3. Key Insights
      10.7.4. Key Strategy
      10.7.5. Product Portfolio
      10.7.6. SWOT Analysis
   10.8. Sorin Group      
      10.8.1. Introduction
      10.8.2. Financials
      10.8.3. Key Insights
      10.8.4. Key Strategy
      10.8.5. Product Portfolio
      10.8.6. SWOT Analysis
   10.9. ELA Medica 
      10.9.1. Introduction
      10.9.2. Financials
      10.9.3. Key Insights
      10.9.4. Key Strategy
      10.9.5. Product Portfolio
      10.9.6. SWOT Analysis
   10.10. Biotronik      
      10.10.1. Introduction
      10.10.2. Financials
      10.10.3. Key Insights
      10.10.4. Key Strategy
      10.10.5. Product Portfolio
      10.10.6. SWOT Analysis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix
   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports